Welcome Dr. Ruffo
OCFM
OCTOBER 23, 2020
October 23, 2020 / Jack Forbush, DO / News Jack Forbush, DO Helpful video out together by one. Notice of Privacy Policy
OCFM
OCTOBER 23, 2020
October 23, 2020 / Jack Forbush, DO / News Jack Forbush, DO Helpful video out together by one. Notice of Privacy Policy
FDA Law Blog
FEBRUARY 9, 2024
We previously blogged on the draft guidance ( here ) and on FDA’s broader framework for Digital Health Technologies (DHT) ( here and here ). The final guidance provides additional discussion with respect to DHTs that meet the definition of a device.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
JANUARY 4, 2023
Brevig, Senior Regulatory Device and Biologics Expert — On December 7, 2022, FDA’s Center for Biologics Evaluation and Research (CBER) and the Office of Tissues and Advanced Therapies (OTAT) held a town hall to answer questions related to cell therapy and tissue-engineered products chemistry, manufacturing, and controls (CMC).
FDA Law Blog
JULY 10, 2023
In this blog post, we will first briefly outline the procedural steps in the 510(k) review process for medical devices. However, the strategy of addressing the AI request presented in the next section of this blog post applies to all three types of 510(k)s. FDA Day (in calendar days) FDA Actions Day 1 FDA receives 510(k) submission.
FDA Law Blog
FEBRUARY 7, 2023
There are many resources that provide information and guidance for each of these required elements. Or, to put it another way: We have not yet met an engineer who enjoys remediating the documents for development work that was done in the past.
FDA Law Blog
OCTOBER 10, 2023
By Philip Won & Véronique Li, Senior Medical Device Regulation Expert — As we recently blogged , FDA released three draft guidance documents to help enhance the predictability, consistency, and transparency of the 510(k) program. One of these documents focuses on “ Evidentiary Expectations for 510(k) Implant Devices.”
FDA Law Blog
DECEMBER 8, 2022
labeling of major food allergens in bulk foods, dietary supplements, protein-free ingredients, and foods produced through genetic engineering); and. 1, 2023; The applicability of food allergen labeling requirements to specific products (e.g., Other technical labeling matters. 1, 2023, sesame. lampreys); Bony fish (e.g., trout); and.
Let's personalize your content